Marburg Virus (MARV) has been wreaking havoc in Africa, with 5 deaths reported from Tanzania in the last 24 hours. Earlier this year, Equatorial Guinea reported an outbreak of MARV with 9 fatalities. This Ebola-like hemorrhagic virus is characterized by symptoms of high fever, followed by bleeding and organ failure. Something that can help the frontline medical workers in their crusade against the virus would be an easy, portable and affordable means of detecting the virus early and increasing the odds and chances of survival.

In the midst of these outbreaks, Berlin-based startup midge medical promptly responded to a request from the Institut Pasteur de Dakar (IPD) to adapt their existing minoo system to better support detection efforts. A partnership with IPD was established for the mutual benefit from the respective experiences in field diagnostics and digital medtech. Within a month, midge medical integrated an isothermal molecular MARV test into their existing platform and delivered a prototype test for field testing in Africa.IPD staff were trained to run the test and the system was verified to work with clinical samples from the recent outbreak. The minoo test station is a small battery-driven, multi-use device for molecular diagnostics; data measured are transferred to a cellular phone, connecting to the backend to analyze the test data and subsequently display the test result to the user. Sample handling steps are comparable to rapid tests known for Corona.

midge medical sells a CE-IVD marked SARS-CoV-2 test kit running on the minoo instrument. In initial responses to the prototype Marburg test on the minoo station, the easy to use, simplicity and protocol of the test earned praise amongst the local teams. IPD staff with field experience participating in the training responded with the following comments in the user questionnaire at the end of the training. “What’s fascinating about minoo is that you get the result directly on your phone" & "The device is easy to use and is perfectly adapted to field conditions", and "The minoo system, responds to the urgent need for sensitive, rapid, and ready-to-use molecular tests." midge medical hopes to continue collaborating with the IPD to adapt and develop its device for urgent needs of virus surveillance and detection in outbreak investigations in Africa.

Über die midge medical GmbH

The medtech start-up midge medical was founded by Michael Diebold in 2016. This Berlin company is specialized in the development of innovative and digital diagnostics systems for patient-based analytics that are scalable beyond national markets and fields of infection. midge medical is thus among the current leading healthcare movers which are taking decisive steps forward in improving digital competitiveness in the healthcare sector.

Firmenkontakt und Herausgeber der Meldung:

midge medical GmbH
Colditzstraße 34/36, 16A
12099 Berlin
Telefon: +49 (30) 62939051
https://midgemedical.com

Ansprechpartner:
Aparna Prabhakar
Project Management
E-Mail: aparna.prabhakar@midge-medical.com
Für die oben stehende Pressemitteilung ist allein der jeweils angegebene Herausgeber (siehe Firmenkontakt oben) verantwortlich. Dieser ist in der Regel auch Urheber des Pressetextes, sowie der angehängten Bild-, Ton-, Video-, Medien- und Informationsmaterialien. Die United News Network GmbH übernimmt keine Haftung für die Korrektheit oder Vollständigkeit der dargestellten Meldung. Auch bei Übertragungsfehlern oder anderen Störungen haftet sie nur im Fall von Vorsatz oder grober Fahrlässigkeit. Die Nutzung von hier archivierten Informationen zur Eigeninformation und redaktionellen Weiterverarbeitung ist in der Regel kostenfrei. Bitte klären Sie vor einer Weiterverwendung urheberrechtliche Fragen mit dem angegebenen Herausgeber. Eine systematische Speicherung dieser Daten sowie die Verwendung auch von Teilen dieses Datenbankwerks sind nur mit schriftlicher Genehmigung durch die United News Network GmbH gestattet.

counterpixel